Tesamorelin/Ipamorelin – Research Compound

Tesamorelin/Ipamorelin is a combined peptide research formulation designed for laboratory investigation of growth hormone–related signaling pathways and the somatotropic axis.

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). In research models, GHRH and its analogues are studied for their interaction with the growth hormone-releasing hormone receptor (GHRH-R), a G protein-coupled receptor involved in signaling processes associated with pituitary growth hormone release.

Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. It has been studied for its activity at the growth hormone secretagogue receptor, also known as the ghrelin receptor or GHS-R1a. Experimental research has characterized Ipamorelin as a selective growth hormone secretagogue and has examined its receptor activity and downstream signaling effects.

Research Interest

The Tesamorelin/Ipamorelin combination may be of interest to researchers studying two distinct but related signaling pathways involved in regulation of the somatotropic axis.

Tesamorelin is associated with GHRH receptor signaling, while Ipamorelin is studied primarily in relation to growth hormone secretagogue receptor signaling. Combining these compounds in a controlled research setting can therefore provide researchers with a model for investigating interactions between GHRH-mediated and GHS-R-mediated pathways.

Potential areas of laboratory investigation include:

• GHRH receptor signaling
• Growth hormone secretagogue receptor activity
• Somatotropic-axis signaling
• Pituitary signaling mechanisms
• Peptide-receptor interactions
• Growth hormone secretion pathways
• Cellular signaling responses
• Metabolic signaling pathways
• Comparative peptide pharmacology
• Experimental endocrine research

About Tesamorelin

Tesamorelin is a synthetic peptide analogue related to endogenous growth hormone-releasing hormone. Research on Tesamorelin and other GHRH analogues has focused on their interaction with GHRH receptors and the signaling mechanisms associated with the hypothalamic-pituitary growth hormone axis.

GHRH receptor activation is associated with intracellular signaling pathways that participate in the regulation of growth hormone secretion. Because of this mechanism, Tesamorelin is frequently studied in laboratory models examining GHRH receptor pharmacology and endocrine signaling.

About Ipamorelin

Ipamorelin is a synthetic pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂.

Research has characterized Ipamorelin as a selective growth hormone secretagogue that acts through growth hormone secretagogue receptors. Early experimental studies demonstrated its ability to stimulate growth hormone release in laboratory models while showing a different selectivity profile from several earlier growth hormone-releasing peptides.

The GHS-R receptor system is also associated with ghrelin signaling and is widely studied in endocrine, metabolic, and receptor-signaling research.

Dual-Pathway Research Model

Tesamorelin and Ipamorelin interact with different receptor systems.

Tesamorelin is primarily associated with the GHRH receptor pathway, whereas Ipamorelin is associated with the growth hormone secretagogue receptor pathway.

This makes the combined formulation particularly relevant for controlled laboratory studies investigating how separate peptide signaling systems may influence related downstream biological pathways.

Researchers may use this material for comparative receptor studies, biochemical assays, analytical characterization, or other appropriately designed in vitro research applications.

Product Information

Product: Tesamorelin/Ipamorelin
Category: Research Compounds
Strength: 10 mg total vial content
Form: Lyophilized powder
Research designation: Research Use Only (RUO)

The product is supplied as a freeze-dried research material in a sealed vial for laboratory analysis and experimental research.

The 10 mg designation refers to the total labeled product content. The individual Tesamorelin-to-Ipamorelin ratio should not be assumed unless specifically identified on the product documentation or Certificate of Analysis.

Laboratory Research Use

This material is intended for qualified researchers conducting controlled scientific investigation. Appropriate laboratory procedures, analytical equipment, and documented experimental protocols should be used when handling research compounds.

Potential research applications may include receptor-binding studies, biochemical characterization, peptide stability studies, analytical testing, signaling assays, and experimental models examining the growth hormone regulatory system.

Important Research Notice

Tesamorelin-containing research materials may exhibit particular physical characteristics during laboratory preparation, including cloudiness, precipitation, gelling, or changes in appearance depending on experimental conditions such as solvent selection, concentration, pH, and handling.

Such physical observations should be evaluated within the context of the laboratory protocol and appropriate analytical testing.

Profound Aminos does not provide clinical dosing, administration, or human-use instructions.

Research Use Only

This product is sold strictly for legitimate laboratory research and scientific investigation.

It is not intended for human or veterinary use, consumption, clinical administration, diagnostic procedures, therapeutic purposes, or use as a food, drug, cosmetic, or dietary supplement.

This product is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition.

All purchasers are responsible for ensuring that research materials are handled in accordance with applicable institutional procedures, regulations, and laboratory safety requirements.